Maria Levada
Gynecology · Valley Stream, NYNPI 1558406215
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,859 of the $2,128 with a category attached, or 87.4%. 21 manufacturers reported payments, led by AbbVie at 25.2% of the total.
Across 91 payments — averaging $23.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$535
- Astellas Pharma US Inc$379
- Exeltis, USA Inc.$226
- Lupin Inc.$168
- Sumitomo Pharma America, Inc.$113
- Revance Therapeutics, Inc.$106
- plus $600 from 15 others
What the payments were for
- Food & beverage$1,85987%
- Education$26813%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 26 | $535 |
| Astellas Pharma US Inc | 11 | $379 |
| Exeltis, USA Inc. | 12 | $226 |
| Lupin Inc. | 3 | $168 |
| Sumitomo Pharma America, Inc. | 5 | $113 |
| Revance Therapeutics, Inc. | 1 | $106 |
| Myovant Sciences Inc. | 5 | $90 |
| Scynexis, Inc. | 5 | $88 |
| Therapeuticsmd, Inc. | 4 | $68 |
| Exact Sciences | 3 | $64 |
| AMAG Pharmaceuticals, Inc. | 3 | $46 |
| Mayne Pharma Commercial LLC | 2 | $43 |
| Millicent US Inc | 2 | $38 |
| Smith+Nephew | 2 | $27 |
| Virtus Pharmaceuticals LLC | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| Acella Pharmaceuticals, LLC | 1 | $21 |
| Agile Therapeutics, Inc. | 1 | $20 |
| Coopersurgical, Inc. | 1 | $19 |
| Pfizer | 1 | $15 |
| Avion Pharmaceuticals | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,128 in reported general payments places this provider in the 75th percentile of 240 gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 68 | $3,939 |
| ProgesteroneProgesterone, Micronized | 38 | $1,558 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 68 | $1,257 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $215 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $102 |
| Alendronate Sodium | 13 | $95 |
| Alprazolam | 25 | $63 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Valley Stream
- Arnold AdvinculaNew York$2.1M
- Stephen CohenSyracuse$204K
- Susan KhalilStaten Island$115K
- Diane SutterKenmore$95K
- Tamara KolevNew York$91K
- Shane SoppSyracuse$84K
- Charles Ascher-WalshNew York$43K
- Paula CastanoNew York$31K
- David KurssWilliamsville$25K
- Navpriya OberoiFayetteville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.